Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J. van der Wilk, Marc J. van Det, Jan Willem T. Dekker et al.|The Lancet Oncology|2025Cited by 95
Preferences for active surveillance or standard oesophagectomy: discrete-choice experimentBerend J. van der Wilk, J. Jan B. van Lanschot, Inge Spronk et al.|British journal of surgery|2021Cited by 8
796. P02.05 NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY ACTIVE SURVEILLANCE VERSUS STANDARD SURGERY FOR OESOPHAGEAL CANCER (SANO-TRIAL): A MULTICENTRE STEPPED-WEDGE CLUSTER-RANDOMISED NONINFERIORITY TRIALBerend Van Der Wilk, J. Jan B. van Lanschot, Ben M. Eyck et al.|Diseases of the Esophagus|2024Cited by 1
793 PATIENTS’ PREFERENCES FOR ACTIVE SURVEILLANCE OR STANDARD ESOPHAGECTOMY AFTER NEOADJUVANT CHEMORADIOTHERAPY: A DISCRETE CHOICE EXPERIMENT IN PATIENTS AFTER STANDARD ESOPHAGECTOMYBerend Van Der Wilk, J. Jan B. van Lanschot, Inge Spronk et al.|Diseases of the Esophagus|2021Cited by 0
Patients’ preferences for active surveillance or standard oesophagectomy: a discrete choice experiment.Berend Van Der Wilk, J. Jan B. van Lanschot, Inge Spronk et al.|European Journal of Surgical Oncology|2022Cited by 0